Hyperion Defi (HYPD) Change in Account Payables (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Change in Account Payables of $110366.0 for Q1 2026, up 111.04% year-over-year from $52296.6 in Q1 2025, and up 113.45% quarter-over-quarter from -$820850.0 in Q4 2025.
Hyperion Defi (HYPD) Change in Account Payables (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Change in Account Payables for 10 consecutive years, with $110366.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 111.04% year-over-year to $110366.0; the TTM figure through Mar 2026 stood at -$526608.0 (up 44.29% YoY), while the FY2025 annual figure was -$1.6 million, down 466.5% from the prior year.
- Change in Account Payables advanced to $110366.0 in Q1 2026 per HYPD's latest filing, from -$820850.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.2 million in Q2 2022 and bottomed at -$1.6 million in Q3 2022.
- Historically, Change in Account Payables has averaged -$55338.3 across 5 years, with a median of $110366.0 in 2026.
- Annual changes were most pronounced in 2022 — Change in Account Payables sank 9351.04% — and 2024, when it surged 1596.17%.
- Hyperion Defi's Change in Account Payables stood at $323324.0 in 2022, then rose by 1.18% to $327144.0 in 2023, then soared by 91.3% to $625828.0 in 2024, then sank by 231.16% to -$820850.0 in 2025, then jumped by 113.45% to $110366.0 in 2026.
- Business Quant data shows HYPD's Change in Account Payables at $110366.0 in Q1 2026, -$820850.0 in Q4 2025, and $237156.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 | -289,152.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -289,152.00 |
| Jun 30, 2026 | -289,152.00 |
| Mar 31, 2026 | 110,366.00 |
| Mar 31, 2026 | 110,366.00 |
| Dec 31, 2025 | -820,850.00 |
| Dec 31, 2025 | -820,850.00 |
| Sep 30, 2025 | 237,156.00 |
| Sep 30, 2025 | 237,156.00 |
| Jun 30, 2025 | -53,280.00 |
| Jun 30, 2025 | -53,280.00 |
| Mar 31, 2025 | -999,807.00 |
| Mar 31, 2025 | -999,807.00 |
| Dec 31, 2024 | 625,828.00 |
| Dec 31, 2024 | 625,828.00 |
| Sep 30, 2024 | 137,276.00 |
| Sep 30, 2024 | 137,276.00 |
| Jun 30, 2024 | -708,608.00 |
| Jun 30, 2024 | -708,608.00 |
| Mar 31, 2024 | 392,100.00 |
| Mar 31, 2024 | 392,100.00 |